28 January 2016 - The U.S. Congress may intervene on how much companies can charge for some drugs following a move last year by Turing Pharmaceuticals to ratchet up the price of a treatment for deadly parasite infections by 5,000 percent, Roche's head of pharmaceuticals said.

For more details, go to: http://news.yahoo.com/roche-expects-cancer-treatments-spared-u-pricing-curbs-145942520--finance.html